Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cancer therapy and p53

S W Lowe1

  • 1Cold Springs Harbor Laboratory, New York, USA.

Current Opinion in Oncology
|November 1, 1995
PubMed
Summary

Apoptosis, programmed cell death, is crucial for tissue balance. Inactivating the p53 tumor suppressor gene promotes cancer growth and resistance to chemotherapy by blocking apoptosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A common functional consequence of tumor-derived mutations within c-MYC.

Oncogene·2014
Same author

Granule exocytosis mediates immune surveillance of senescent cells.

Oncogene·2012
Same author

The Polycomb complex PRC2 supports aberrant self-renewal in a mouse model of MLL-AF9;Nras(G12D) acute myeloid leukemia.

Oncogene·2012
Same author

Mast-cell leukemia exome sequencing reveals a mutation in the IgE mast-cell receptor β chain and KIT V654A.

Leukemia·2011
Same author

Transgenic, inducible RNAi in megakaryocytes and platelets in mice.

Journal of thrombosis and haemostasis : JTH·2010
Same author

AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma.

Oncogene·2010

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Death Studies

Background:

  • Apoptosis is vital for maintaining tissue homeostasis.
  • Dysregulation of apoptosis contributes to cancer development and treatment resistance.
  • The p53 tumor suppressor gene product is a key regulator of apoptosis.

Purpose of the Study:

  • To explore the role of p53 in regulating apoptosis in cancer cells.
  • To investigate the link between p53 mutations and resistance to cancer therapy.
  • To identify p53 as a potential therapeutic target for overcoming treatment resistance.

Main Methods:

  • Review of recent studies on p53 and apoptosis.
  • Analysis of clinical data implicating p53 mutations in therapy resistance.
  • Correlation of p53 status with apoptotic response to cytotoxic agents.

Main Results:

  • Inactivation of p53 is associated with impaired apoptosis in tumor cells.
  • Mutations in p53 correlate with resistance to various cancer therapies.
  • Loss of p53 function attenuates the apoptotic response to anticancer drugs.

Conclusions:

  • Inactivation of p53 promotes resistance to anticancer agents by inhibiting apoptosis.
  • Targeting p53 offers a promising strategy to enhance cancer therapy efficacy.
  • Restoring p53 function or bypassing its pathway could overcome treatment resistance.

Related Experiment Videos